1 month ago
Published [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year]
Cognizant services will supply automation and integer technologies that tin trim costs of work and velocity clip to market
TEANECK, N.J., March 25, 2024 /PRNewswire/ -- Cognizant (NASDAQ: CTSH) announced coming it has been selected by Clario, a healthcare investigation exertion institution that delivers starring endpoint exertion solutions for objective trials, to support its world IT infrastructure and applications. The collaboration will thief Clario beforehand its worker and customer offerings successful support of its ngo to toggle shape lives by generating high-quality grounds for much informed determination making.
“At Clario, we pridefulness ourselves connected providing nan champion exertion for our customers and we do that by creating a robust and innovative ecosystem,” said Jay Ferro, EVP, Chief Information, Technology & Product Officer astatine Clario. “Cognizant’s innovative exertion and manufacture expertise made them nan earthy prime to partner connected nan adjacent shape of our integer translator journey.”
Clario develops integer solutions that redefine possibilities successful objective tests by enhancing nan accuracy, reliability, speed, and ratio of information gathering and analysis. Over nan people of nan five-year relationship, Clario will leverage Cognizant’s acquisition successful automation and integer technologies for process and acquisition modernization, supporting:
- Achieving faster clip to marketplace by streamlining workflows and enhancing collaboration crossed teams.
- Building a instauration for a integer endeavor by integrating data, analytics, and AI capabilities crossed nan company.
- Driving cutting separator invention successful nan objective tests abstraction by adopting agile methodologies and champion practices.
“Clinical tests require unafraid and reliable exertion to negociate diligent data, show results, guarantee regulations are met, and more.” said Cognizant’s Mohammad Haque, SVP, Global Large Deals Lead and BU Head, Life Sciences. “Clario is doing groundbreaking activity successful providing this exertion to tally objective trials, and Cognizant is excited to activity alongside them to modernize their offerings.”
About Cognizant
Cognizant (Nasdaq: CTSH) engineers modern businesses. We thief our clients modernize technology, reimagine processes and toggle shape experiences truthful they tin enactment up successful our fast-changing world. Together, we’re improving mundane life. See really astatine www.cognizant.com aliases @cognizant.
About Clario
Clario is simply a starring healthcare investigation and exertion institution that generates nan highest value objective grounds for pharmaceutical, biotech, and aesculapian instrumentality partners. They connection broad grounds procreation solutions that harvester eCOA, cardiac safety, aesculapian imaging, precision motion, and respiratory endpoints.
Clario’s world squad of science, technology, and operational experts person helped present complete 26,000 tests and contributed to complete 800 regulatory approvals successful much than 100 countries. For much than 50 years, they person delivered heavy technological expertise and nan astir broad endpoint technologies to thief toggle shape lives astir nan world.
View original contented to download multimedia: https://www.prnewswire.com/news-releases/clario-selects-cognizant-as-global-strategic-technology-services-provider-to-optimize-and-advance-their-clinical-transformation-journey-302097723.html
SOURCE Cognizant Technology Solutions Corporation
